Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 3
1957 1
1959 1
1960 1
1963 2
1964 1
1967 1
1968 2
1969 2
1971 1
1976 1
1977 2
1978 6
1979 3
1980 2
1981 4
1982 6
1983 3
1984 3
1985 2
1986 9
1987 4
1988 9
1989 6
1990 7
1991 5
1993 5
1994 5
1995 7
1996 3
1997 14
1998 12
1999 10
2000 15
2001 30
2002 10
2003 13
2004 14
2005 7
2006 12
2007 14
2008 13
2009 13
2010 15
2011 16
2012 18
2013 16
2014 19
2015 27
2016 18
2017 19
2018 18
2019 13
2020 25
2021 22
2022 35
2023 29
2024 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

529 results

Results by year

Filters applied: . Clear all
Page 1
Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis.
Burmester GR, Cohen SB, Winthrop KL, Nash P, Irvine AD, Deodhar A, Mysler E, Tanaka Y, Liu J, Lacerda AP, Palac H, Shaw T, Mease PJ, Guttman-Yassky E. Burmester GR, et al. Among authors: cohen sb. RMD Open. 2023 Feb;9(1):e002735. doi: 10.1136/rmdopen-2022-002735. RMD Open. 2023. PMID: 36754548 Free PMC article. Clinical Trial.
The Tuberculous Granuloma and Preexisting Immunity.
Cohen SB, Gern BH, Urdahl KB. Cohen SB, et al. Annu Rev Immunol. 2022 Apr 26;40:589-614. doi: 10.1146/annurev-immunol-093019-125148. Epub 2022 Feb 7. Annu Rev Immunol. 2022. PMID: 35130029 Review.
CD4-mediated immunity shapes neutrophil-driven tuberculous pathology.
Gern BH, Klas JM, Foster KA, Cohen SB, Plumlee CR, Duffy FJ, Neal ML, Halima M, Gustin AT, Diercks AH, Aderem A, Gale M Jr, Aitchison JD, Gerner MY, Urdahl KB. Gern BH, et al. Among authors: cohen sb. bioRxiv [Preprint]. 2024 Apr 15:2024.04.12.589315. doi: 10.1101/2024.04.12.589315. bioRxiv. 2024. PMID: 38659794 Free PMC article. Preprint.
Laparoscopic hysterectomy.
Wattiez A, Cohen SB, Selvaggi L. Wattiez A, et al. Among authors: cohen sb. Curr Opin Obstet Gynecol. 2002 Aug;14(4):417-22. doi: 10.1097/00001703-200208000-00009. Curr Opin Obstet Gynecol. 2002. PMID: 12151832 Review.
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group. Cohen SB, et al. Arthritis Rheum. 2006 Sep;54(9):2793-806. doi: 10.1002/art.22025. Arthritis Rheum. 2006. PMID: 16947627 Free article. Clinical Trial.
Malignancy and Janus Kinase Inhibition.
Sivaraman P, Cohen SB. Sivaraman P, et al. Among authors: cohen sb. Rheum Dis Clin North Am. 2017 Feb;43(1):79-93. doi: 10.1016/j.rdc.2016.09.008. Rheum Dis Clin North Am. 2017. PMID: 27890175 Review.
529 results